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Introduction
Carbohydrates are broadly important molecules in
cells and tissues that provide structural assemblies,
metabolic energy, and store information as disparate
as blood group, intercellular recognition signals, and
trafficking commands within their sequences.1 Cell
surface saccharides are well-known regulators of
cell-to-cell interactions and downstream signal trans-
duction events in developmental and host defense
pathways.2,3 For example, one mechanism regulat-
ing leukocyte trafficking is mediated by selectins,
which are lectins expressed by leukocytes, endothe-
lial cells, platelets, and other cell types.4 Selectins
recognize the terminal tetrasaccharide sequence:
NeuAca2 fi 3Galb1 fi 4[Fuca1 fi 3]GlcNAcb1 (sLeX).
Selectins mediate initial leukocyte–endothelial cell
contact leading to tight integrin-mediated contact
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Problem
To better understand the immunoregulatory properties of trophoblasts,
we have searched for small immunologically active carbohydrates
derived from intact trophoblast-like cells.
Method of study
Using solid phase extraction coupled with HPLC and mass spectrometry
methods, we have characterized a low molecular weight carbohydrate-rich
fraction associated with JEG-3 cells. We have also tested the bioactivities
of selected authentic oligosaccharides found in the oligosaccharide fraction.
Results
The most abundant components of the low molecular weight carbohy-
drate-rich fraction were maltotriose and maltotetraose, with detectable
amounts of maltopentaose. When authentic maltooligosaccharides were
tested using lymphocytes, IL-2 inhibition was observed. This activity
was dependent upon the number of saccharide subunits, stereochemis-
try, and concentration. To further test maltooligosaccharide properties,
maltopentose was attached to glass cover slips. Although spontaneous
neutrophil motility was observed on unmodified and control surfaces, it
was inhibited on maltooligosaccharide-derivatized surfaces.
Conclusion
Maltooligosaccharides are associated with the trophoblast’s surface
where they may exhibit immunoregulatory activities.
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and subsequent extravasation.4 Other cell surface
receptors such as complement receptor type 3 and
dectin-1 bind to polysaccharides and oligosaccharides
known as b-1,3-d-glucans, which are found in yeast
cell walls.5 Hence, oligosaccharides play central roles
in adaptive and innate immune responses with
relevance to infectious diseases, autoimmunity, and
cancer.6,7
An important physiological niche exhibiting modi-
fied leukocyte function is the maternal–fetal inter-
face. For example, trophoblasts have been shown to
protect the conceptus from destruction by activated
macrophages.8 Moreover, macrophages activated by
multiple mechanisms display cytotoxicity against
tumor cell targets, but not trophoblasts.9 Included
among the various molecules proposed to influence
leukocyte activation in pregnancy are carbohydrates.
Previous studies by Arkwright et al.10 demonstrated
that neutral oligosaccharides of syncytiotrophoblast
membranes suppress allogeneic reactivity using the
mixed lymphocyte reaction assay. Muchmore et al.11
have suggested that the disaccharide a-d-Man-
(1 fi 6)-a-d-Man, derived from pregnancy urine, is
capable of inhibiting early events during lymphocyte
proliferative responses. We have found that maltool-
igosaccharides can be released from JEG-3 tropho-
blast-like cells, and that these saccharides reduce
IL-2 production by stimulated Jurkat lymphocytes at
concentrations expected for interfacial cell–cell inter-
actions. Furthermore, when attached to substrates,
maltooligosaccharides reduce the spontaneous motil-
ity of neutrophils. We speculate that maltooligo-




Maltotriose, maltotetraose, maltopentaose, cellotri-
ose, isomaltotriose, and panose, were obtained from
Sigma-Aldrich (St. Louis, MO, USA). Alexa-488-con-
jugated phytohemagglutinin (PHA) was obtained
from Molecular Probes (Eugene, OR, USA).
Neutrophils
Peripheral blood was collected from healthy human
donors in compliance with the guidelines of the Univer-
sity of Michigan Institutional Review Board for Human
Subject Research. Neutrophils were isolated using Fi-
coll-Histopaque (Sigma) density gradient centrifugation,
resuspended and washed in PBS by centrifugation.
Lymphocytes
Jurkat cells (ATCC, Manassas, VA, USA) were main-
tained in RPMI-1640 medium (Invitrogen, Carlsbad,
CA, USA) containing 10% FCS and 1% antibiotics.
JEG-3 Trophoblasts
JEG-3 cells, derived from human choriocarcinoma,
were obtained from the ATCC. JEG-3 cytotrophoblast-
like cells were grown in RPMI 1640 containing 10%
FCS and 1% penicillin G ⁄ streptomycin ⁄ amphotericin
B (Invitrogen). The cell line was occasionally replaced
with the original cell line as a quality control measure.
Cell Treatment
As many as 10–20 tissue culture flasks were used in
each treatment. JEG-3 cells on tissue culture plates
were washed with PBS (without Ca2+ and Mg2+;
Invitrogen) then incubated with PBS (without Ca2+
and Mg2+) on a shaker at 37C for 24 hr to non-
lytically promote the release of glycocalyx materials
without cell debris. Alternatively, in some experi-
ments cells were incubated with recombinant PNF-
ase F (BioLabs, Boston, MA, USA) (10 min at 37C)
to promote the release of these materials. After the
supernatant was collected from multiple flasks, the
combined supernatants were ultrafiltrated with
CentriPlus filter (YM-10; Millipore, Billerica, MA,
USA), which has a molecular weight cutoff of 10 K,
to isolate a low molecular weight fraction. As nega-
tive controls, other cell lines (e.g., Jurkat cells) were
subjected to the same experimental conditions. The
samples were stored at )80C until used.
Concentration and Desalting of Samples
A non-porous graphitized carbon column (4 mL, Carb-
ograph SPE; Alltech, Deerfield, IL, USA) was pre-acti-
vated with 2 mL of 25% MeOH and 2 mL of water.
Thirty milliliters of sample was passed through the col-
umn at a flow rate of 1 mL ⁄ min. The column was
washed with water to remove salts and then eluted
with 2 mL of 25% MeOH in 10 lm NH4OAc to obtain
the oligosaccharide fraction.12,13 The eluate was con-
centrated to 0.5 mL in a Speed-Vac evaporator
(Thermo Fisher Sci., Waltham, MA, USA).
IMMUNOREGULATORY PROPERTIES OF MALTOOLIGOSACCHARIDES
American Journal of Reproductive Immunology 65 (2011) 54–64
ª 2010 John Wiley & Sons A/S 55
Electrospray Mass Spectrometry
Electrospray ionization mass spectrometry (ESI-MS)
spectra were recorded on a ThermoElectron Finnigan
LTQ linear ion trap mass spectrometer equipped with
an electrospray ionization source. Full scan mass range
m ⁄ z was 100–2000. For positive-ion mode MS experi-
ments, the ESI voltage was set at 3.2 kV, the capillary
voltage at 25.5 V, and the tube lens voltage at 131 V.
For negative mode MS experiments, the ESI voltage
was set at )2.1 kV, the capillary voltage at )25 V, and
tube lens voltage at )79 V. The capillary temperature,
sheath gas, and auxiliary gas were 250C, 20 units, and
5 units, respectively, for both modes.
High-Performance Anion-Exchange
Chromatography (HPAEC) Analysis
The chromatography system was a Dionex (Sunny-
vale, CA, USA) BioLC, which included a GP50 gradi-
ent pump and an ED50A electrochemical detector.
The standard carbohydrate waveform was used
for ED50A. Oligosaccharides were separated on a
CarboPac PA100 column (9 · 250 mm; Dionex) with
0.1 m NaOH as solvent A and 0.1 m NaOH ⁄ 0.5 m
NaOAc as solvent B. The following linear gradient
was used: 0–12.5% B for 15 min, and then increased
to 25% B for 25 min.
IL-2 Production
Aliquots of 106 cells ⁄ mL ⁄ well of Jurkat cells (clone
E6-1) were treated with various concentrations of
maltooligosaccharides (DP3, DP4, DP5, DP6; DP is
the degree of polymerization), isomaltotriose, cello-
triose, and panose (Sigma) in the presence or
absence of the stimulant PHA (10 lg ⁄ mL) for 24 hr
in a 5% CO2 incubator at 37C. Culture super-
natants were collected for IL-2 measurement using a
kit from R&D Systems (Minneapolis, MN, USA).
Briefly, supernatants were incubated in the anti-IL-2
antibody-coated plates at room temperature for 2 hr;
after washing, plates were incubated with horser-
adish peroxidase (HRP)-conjugated secondary anti-
body at room temperature for another 2 hr before
color generation. Optical density was measured by a
Spectra Max 190 (Molecular Devices, Sunnyvale,
CA, USA).
PHA Receptor Staining
Jurkat cells were pre-treated with 20 mm DP4 or
DP5 at room temperature for 30 min followed by
the addition of 10 lg ⁄ mL Alexa-488-PHA (Molecular
Probes) for an additional 30 min. Microscopy was
performed as described later.
Synthesis of Maltooligosaccharide Surfaces
As maltooligosaccharides are highly soluble in water
and adsorb poorly to glass, we covalently linked DP5
to glass surfaces. The synthetic organic preparation
was carried out as outlined in the Scheme 1. Briefly,
glass cover slips (25 · 25 mm, Corning Glass Works,
Corning, NY, USA) were cleaned for 30 min in 0.1 m
NaOH followed by 30 min in concentrated H2SO4
then rinsed exhaustively with deionized water. After
drying under a nitrogen flow, silanization was per-
formed for 2 hr in 10% v ⁄ v 3-aminopropyltrimeth-
oxysilane solution in toluene. The cover slips were
rinsed sequentially with toluene, ethanol, and deion-
ized water, respectively. After drying, the cover slips
were treated with 10-mm DP5 or cellotriose (b-d-
Glc-(1 fi 4)-b-d-Glc-(1 fi 4)-d-Glc) in DMSO ⁄ AcOH
(17:3) for 2 hr and followed by 1 m NaBH3CN in
DMSO for 3 hr. After the synthetic procedure was
complete, the modified cover slips were washed with
DMSO and deionized water in that order.
Scheme 1 Immobilization of DP5 on the sur-
face of cover slips.
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Neutrophil Spontaneous Motility
The spontaneous motility of neutrophils was assessed
using time-lapse optical microscopy. Control or oli-
gosaccharide-modified cover slips were employed.
Cells were allowed to acclimate to the surface at
37C for one hour. A low magnification field was
then chosen to permit visualization of 50–60 cells. A
time series of images was taken using a QImaging
Retiga 1300 camera (QImaging, Surrey, BC, Canada)
and a 40x ⁄ 0.6 NA Nikon Plan Fluor objective (Nikon
Inst., Inc., Melville, NY, USA). The series of photo-
graphs were taken at a rate of 1 ⁄ min using Meta-
Morph software. Cell movement was scored over
30 min, with movement being defined as a cell mov-
ing at least 10 lm, or the approximate average diam-
eter of a neutrophil. Cells were tagged using the
manual count function in MetaMorph, and results
were tabulated and plotted using Microsoft Excel.
Microscopy
Cells were observed using a Nikon Eclipse TE2000
Quantum inverted fluorescence microscope (Nikon
Instruments, Inc., Melville, NY, USA) with mercury
illumination interfaced to a computer using Meta-
morph (Molecular Devices, Danville, PA, USA) soft-
ware. Images were taken with an Andor
Technologies iXon model DV8 16-bit electron multi-
plying CCD camera cooled to )90C (Andor Tech-
nologies, South Windsor, CT, USA). A filter module
comprised of a D470 ⁄ 40x exciter, 505DCLP dichroic,
and an E515LPv2 emitter was used for imaging
Alexa-488-conjugated PHA. Time-lapse imaging was
performed in transmitted bright field imaging using




The low molecular weight carbohydrate-rich fraction
obtained by using the protocol described earlier was
analyzed by MS. In the positive-ion mode (Fig. 1a),
there are two major ions at m ⁄ z 527.4 and 689.5,
whereas in the negative-ion MS mode, more major
ions were observed (503.1, 539.3, 563.1, 665.2,
701.2, 725.1, 677.3, 839.3, and 611.3) (Fig. 1b).
When the positive-ion mode species at m ⁄ z 527.4
and 689.5 were further investigated using MS2, they
showed typical oligosacchride characteristics in their
spectra (see Fig. 1c,d). In the negative-ion mode, we
assign m ⁄ z 503.1 and 665.2 as a trisaccharide (M1)
and tetrasaccharide (M2), respectively. Furthermore,
the species at m ⁄ z 539.3 and 563.1 are [M1+Cl]) and
[M1+CH3CHOO]




the positive mode, the species at m ⁄ z 527.2 and
689.2 are sodium adducts of M1 and M2. The com-
ponent at m ⁄ z 611.3 is glutathiol (confirmed by
multi-MS and HPLC). The species at m ⁄ z 677.3 and
839.3 also exhibit oligosaccharide characteristics;
they are likely adducts of M1 and M2 (677.3 =
[M1+173]
), 839.3 = [M2+173]
)). As the m ⁄ z 527.4
peak of Fig. 1a appears as a breakdown product in
the MS2 spectrum of the m ⁄ z 685.5 component in
Fig. 1d, as well as several smaller fragments, M1 is a
fragment of M2. Therefore, we focused on the struc-
tural analysis of M1.
Further experiments were performed to better
understand the nature of M1. The fragmentation
pattern in positive-ion mode MS may not be struc-
ture-specific. For example, oligosaccharides may be
protonated at several positions, resulting in a potential
lack of linkage specificity. Consequently, most carbo-
hydrate linkage determinations have been performed
using negative-ion mode MS. However, in our experi-
ments using Na+ adducts, the positive-ion MS mode
gave us more structural information. Moreover, the
sensitivity was improved dramatically in comparison
with the negative-ion mode. In these experiments,
three commercially available trisaccharides containing
glucose with differences in the anomeric carbon and
linkage positions were selected as standard samples for
comparison with M1. These saccharides were maltotri-
ose (a-d-Glc-(1 fi 4)-a-d-Glc-(1 fi 4)-d-Glc), cellotri-
ose (b-d-Glc-(1 fi 4)-b-d-Glc-(1 fi 4)-d-Glc), panose
(a-d-Glc-(1 fi 6)-a-d-Glc-(1 fi 4)-d-Glc), and iso-
maltotriose (a-d-Glc-(1 fi 6)-a-d-Glc-(1 fi 6)-d-Glc).
Like M1, these trisaccharides only exhibit sodium ad-
ducts, because the sodiated ions are more stable than
their protonated counterparts in positive-ion mode
MS (Fig. 2). Fig. 2 shows that trisaccharides with dif-
ferent linkages (1 fi 4 and 1 fi 6) and anomeric con-
figurations (a and b) show different fragmentation
profiles. The molecular weight and MS2 spectrum of
maltotriose are identical to that of M1, indicating the
identity of these two molecules. These findings are
summarized in Fig. 3, which shows the molecular
fragments corresponding to the peaks given in Figs 1
and 2 as well as the measured abundances of these
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various fragments for the listed panel of glucose-con-
taining isomeric trisaccharides. These data further
support the identification of M1 as maltotriose.
To provide an independent line of evidence to test
the correspondence of M1 with maltotriose, we per-
formed HPAEC analyses for M1, M2, maltotriose, and
maltotetraose under identical conditions. The chro-
matographs are shown in Fig. 4. Fig. 4a shows the
separation of solid phase extraction (SPE) fraction.
Two major peaks with retention times of 21.97 and
27.00 min are observed. These two peaks correspond
to the most abundant molecules in the extract,
namely M1 and M2. The retention times and the
shapes of peaks match well with those of authentic
maltotriose and maltotetraose (Fig. 4b,c). Hence, the
two major compounds released from JEG-3 cells
were maltotriose and maltotetraose, which were
determined by electrospray mass spectroscopy
(ESI-MS) and HPAEC. Although maltooligosaccha-
rides were found to be associated with JEG-3 cells, it
is possible that they originated in the culture med-
ium then adsorbed to the cells. When the cell
growth medium was examined by HPAEC, malt-
ooligosaccharies could not be detected (data not
shown), thus indicating that the maltooligosaccha-
rides originate from the cells, not the culture med-
ium. As a negative control experiment, we found
that maltooligosaccharides could not be isolated from
Jurkat cells (data not shown).
Functional Studies
Previous studies from other laboratories10 have sug-
gested that trophoblast oligosaccharides exhibit
immunoregulatory capacity. To test the potential
immunoregulatory capacity of maltooligosaccharides,
(a) (b)
(c) (d)
Fig. 1 Mass spectrometry of trophoblast oligosaccharides. Mass spectroscopy (MS) spectra of SPE fraction in the positive-ion mode (panel a) and
negative-ion mode (panel b) are shown. In addition, MS2 spectra of m ⁄ z 527.4 (panel c) and m ⁄ z 685.5 (panel d) in the positive-ion mode are
given. The similarities in these fragmentation patterns in panels c and d suggest structural similarities in these two compounds.
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Fig. 3 Relative abundances of fragments for
M1 and standard trisaccharides using the frag-
mentation nomenclature of Domon and Cos-
tello.29 This analysis shows clearly the
correspondence between M1 and maltotriose.
(a) (b)
(c) (d)
Fig. 2 Analysis of a family of structural isomers. MS2 of maltotriose, cellotriose, panose, and isomaltotriose in the positive-ion mode are shown in
panels a–d, respectively. Note that panel a in this figure is identical to panel c in Fig. 1. MS, mass spectroscopy.
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Jurkat T cells were tested for IL-2 production during
treatment with various oligosaccharides. In the first
series of experiments a saccharide concentration of
20 mm was used because it approximates the interfa-
cial maltooligosaccharide concentration expected at a
site of cell–cell contact. Cells were incubated with or
without PHA for 24 hr at 37C. As shown in Fig. 5,
the isomers cellotriose (b-d-Glc-(1 fi 4)-b-d-Glc-
(1 fi 4)-d-Glc) and isomaltotriose (a-d-Glc-(1 fi 6)-
a-d-Glc-(1 fi 6)-d-Glc) did not have a statistically
significant effect on IL-2 production. However, DP3,
DP4, and DP5 increasingly reduced IL-2 production,
reaching about 50% inhibition for DP5 at 20 mm. DP6
had somewhat less efficacy than DP5, which is likely
because as the sequence nears DP7, the conformation
becomes more circular in shape.14 These findings
strongly suggest that the reported effects are specific,
as small changes in oligosaccharide stereochemistry
resulted in significant changes in IL-2 production.
We also examined the dose–response properties of
maltooligosaccharides. In this series of experiments
we incubated T cells with various concentrations of
DP4 and DP5, as described in the previous para-
graph. As shown in Fig. 6a,b, respectively, DP4 and
DP5 dose-dependently inhibit IL-2 production by
Jurkat T cells. At higher concentrations, DP5 was
somewhat more effective than DP4. At 40 mm, DP5
reduced IL-2 production to about 30% of control
values. Hence, maltooligosaccharides significantly
inhibit the production of IL-2 by T cells.
Although maltooligosaccharides do not resemble
the complex oligosaccharides recognized by PHA, we
nonetheless controlled for the possibility that DP4 and
DP5 blocked the binding of PHA to Jurkat cell sur-




Fig. 4 HPAE chromatographs for the SPE fraction (panel a), as well as
authentic maltotriose (panel b) and maltotetraose (panel c) are shown.
The chromatogram peaks for the trophoblast carbohydrate sample at
22 and 27 min agree with those of maltotriose and maltotetraose.
Fig. 5 Effect of various saccharides on IL-2 production by Jurkat cells.
Cells were stimulated with 10 lg ⁄ mL phytohemagglutinin (PHA) in the
absence or presence of DP3, DP4, DP5, DP6, iDP3 (isomaltotriose),
and cellotriose (all at 20 mM). The saccharide most effective at block-
ing IL-2 production was DP5 (PHA versus DP3 and DP4, P < 0.005;
PHA versus DP5 and DP6, P < 0.001; iDP3 versus DP4, DP5 and DP6,
P < 0.001; iDP3 versus DP3, P < 0.005).
Fig. 6 Effect of DP4 (panel a) and DP5 (panel b) on IL-2 production by Jurkat cells. Cells were treated with various concentrations of DP4 or DP5
in the presence or absence of 10 lg ⁄ mL phytohemagglutinin (PHA) for 24 hr at 37C. IL-2 production was assessed using an ELISA kit and plate
reader. A dose-dependent reduction in IL-2 release was observed, although DP5 exhibited greater efficacy than DP4 (For DP4 and DP5, PHA versus
2.5, 5.0, 10, 20, and 40 mM, P < 0.005).
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for 30 min followed by the addition of Alexa-488-
PHA for 30 min. Fig. 7 shows fluorescence micro-
graphs of Jurkat cells labeled with Alexa-488-PHA
after incubation in the absence of oligosaccharides
(Fig. 7a) or the presence of DP4 or DP5 (Fig. 7b,c,
respectively). As these data show, there were no
significant differences in the PHA labeling of Jurkat
cells during these various conditions. Hence, the dif-
ferences in IL-2 production cannot be accounted for
by competition of the maltooligosaccharides with cell
surface oligosaccharides for PHA binding.
To ascertain the breadth of its potential immuno-
regulatory capacity, we examined the ability of
neutrophils to undergo spontaneous motility on mal-
tooligosaccharide-modified glass cover slips. These
covalently modified cover slips were prepared as
described in the Materials and Methods. Neutrophils
were added to these cover glass-bottom Petri dishes,
then allowed to settle and attach to the surface for
1 hr at 37C. To avoid confounding maltooligo-
saccharide effects with those of chemokinetic and
chemotaxis effects, we examined spontaneous neu-
trophil motility. Motile cells were defined as those
that moved at least one cell diameter during a timed
observation period. Roughly one-half of the neu-
trophils demonstrated motility on unmodified glass
surfaces (Fig. 8). However, this was significantly
reduced (P < 0.001) on cellotriose-modified surfaces
to about 20%. On DP5-modified surfaces, the motile
cell percentage was reduced to about 4%, a dramatic
reduction in cell movement. It is not surprising that
some inhibition was obtained on cellotriose-modified
surfaces because it is a glucose-based oligosaccharide
whose sequence differs only in the anomeric carbon
atom (b versus a) in comparison with maltooligo-
saccharides. Hence, maltooligosaccharides have
immunoregulatory potential.
Discussion
In this study, we have found that maltooligosaccha-
rides can be released from JEG-3 trophoblast-like
cells and that these maltooligosaccharides may influ-
ence the behavior of leukocytes. Although the
mechanisms responsible for maternal immunoregu-
lation have not been completely described, emerging
evidence suggests that they are multifactorial in nat-
ure and involve both adaptive and innate immune
responses. For example, trophoblasts do not express
immunostimulatory HLA class I antigens, but rather
express HLA-G molecules, which promote toler-
ance.15,16 As trophoblasts express B7-H2 and B7-H3
molecules, which interact with members of the
CD28 family on lymphocytes, trophoblasts are prone
to stimulate Th2-type responses.17 Production of the
immunoregulatory enzyme indoleamine-2,3-dioxy-
genase may also contribute to immunoregulation
during pregnancy.18 Although trophoblasts have
been shown to protect the conceptus from destruc-
tion by activated macrophages8 and evade destruc-
tion by activated tumoricidal macrophages,9 the
Fig. 8 Effect of surface-bound oligosaccharides on spontaneous neu-
trophil motility. Surfaces were prepared as outlined in Scheme 1. Neu-
trophils were added to unmodified glass cover slips (panel a) (n = 4),
cellotriose-modified glass cover slips (panel b) (n = 8), or DP5-modified
glass cover slips (panel c) (n = 9). Cells moving 10 lm or more during
the incubation period were scored as positive. DP5-derivatized sur-
faces that displayed four glucose subunits (Scheme 1) dramatically
inhibited spontaneous motility in comparison with both unmodified
and cellotriose-modified glass surfaces (uncoated versus DP5,
P < 0.0001; uncoated versus cellotriose, P = 0.0005; cellotriose versus
DP5, P = 0.0001).
(a) (b) (c)
Fig. 7 Effect of maltooligosaccharides on phytohemagglutinin (PHA)
binding to lymphocytes. Cells were incubated with buffer (panel a),
20 mM DP4 (panel b), or 20 mm DP5 (panel c) for 30 min followed by
the addition of 10 lg ⁄ mL Alexa-488-PHA for 30 min at 37C. Samples
were then washed by centrifugation and observed by fluorescence
microscopy. As no significant differences in binding intensity or loca-
tion were observed, these maltooligosaccharides do not inhibit the
binding of PHA to cells.
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regulation of the innate immune response in preg-
nancy is also incompletely understood. Maltooligo-
saccharides may be another local regulatory factor
influencing the behavior of immune cells. As the
JEG-3 line is derived from a choriocarcinoma, mal-
tooligosaccharides may also be relevant in the con-
text of leukocyte interactions with choriocarcinoma
cells to deflect immune effector function. Thus, our
findings may be relevant to one or more areas of
reproductive immunology.
Previous studies have suggested that pregnancy-
associated carbohydrates, including those at the tro-
phoblast’s surface, affect the behavior of immune
cells.10,11,19,20 Although the structures of some of
these compounds are known, the remainder of these
potential immunoregulatory molecules is unknown.
In this study, we first identified a major low molecu-
lar weight cell surface saccharides of JEG-3 cyto-
trophoblast-like cells then evaluated their
bioactivity. To accomplish the first goal, we used
high-HPAE with pulsed amperometric detection
(HPAE-PAD), which is one of the most powerful
techniques for underivated carbohydrate analysis, in
conjunction with HPLC-ES-MS and MS2. Using these
tools, we determined the structures of two compo-
nents of this fraction to be maltotriose and maltotet-
raose. Interestingly, the accumulation of maltotriose
and maltotetraose in a cell surface fraction of syncy-
tiotrophoblasts has been noted,21 although they did
not determine if maltooligosaccharides were exter-
nally expressed and their biological role was not
addressed. Our structural analysis of JEG-3 cyto-
trophoblast-like oligosaccharides demonstrates that
maltooligosaccharides are a significant carbohydrate
structure of these cells. These maltooligosaccharides
must be synthesized by JEG-3 cells and are presum-
ably non-covalently associated with the cell surface
in a fashion similar to hyaluronan and other glyco-
calyx components.
As previous studies have indicated that trophoblast
membranes22,23 and, specifically, their membrane-
associated saccharides,10 affect lymphocyte function,
we assessed cytokine production by PHA-activated
Jurkat lymphocytes. We found that maltooligosac-
charides reduce cytokine release in a dose-dependent
fashion, with an optimal chain length of DP5. This
optimal chain length is likely because of the forma-
tion of secondary structures, such as rings, at longer
chain lengths.14 However, the use of millimolar con-
centrations of maltooligosaccharides in these experi-
ments might seem too high. Although this may
appear to be high, it is roughly what one would
expect for a region of intercellular contact. Using
HPAE chromatography of SPE isolates and authentic
DP3, we estimate that 4 · 10)9 mol of DP3 can be
isolated from 107 cells. Given the assumptions that
the cell surface area equals 800 lm2 and that mal-
tooligosaccharides are uniformly distributed on their
surfaces, we estimate 3 · 105 molecules of DP3 per
lm2. With approximately equal abundances of
DP3 and DP4, a maltooligosaccharide value of
6 · 105 molecules of per lm2 is suggested, which is
roughly a quarter of the density of phospholipids in
a membrane (2.5 · 106 ⁄ lm2). We estimate that mal-
tooligosaccharides may be distributed in a zone with
a thickness of 0.04 lm. This does not seem unrea-
sonable because the trophoectoderm and apical uter-
ine epithelial membranes at the time of implantation
approach as close as 0.0075–0.015 lm.24 It is also
consistent with the fact that the leukocyte glycocalyx
is 0.012 nm in thickness.25 Using a thickness
of 0.04 lm, we conservatively estimate a local
concentration of 24 mm. Hence, for the biological
conditions of intercellular contact, the concen-
trations used in this study do not appear to be
unreasonable.
Early studies have also suggested that trophoblasts
affect the behavior of adherent mononuclear phago-
cytes.8,9 To test this possibility in our maltooligosac-
charide system, we synthesized DP5-modified glass
cover slips (Scheme 1). In addition, the surface-asso-
ciated DP5 is a better model of the trophoblast sur-
face (both are essentially two-dimensional), in
contrast to the bulk addition of DP5 in the lympho-
cyte experiments. As phagocytic cells are adherent,
these surfaces allowed us to test the hypothetical
bioactivity of DP5 in a chemically robust system
while retaining a physiologically appropriate surface
context for the assessment of bioactivity. Our experi-
mental findings showed that spontaneous neutrophil
motility was reduced on DP5-modified surfaces. This
is consistent with other work suggesting that small
oligosaccharides, including maltooligosaccharides,
affect phagocyte functions such as oxidant produc-
tion.14 Although speculative, it is possible that mal-
tooligosaccharides may act by diminishing glucose
transport, a previously reported attribute of tropho-
blast membrane fragments,26 Thus, the biological
activities of both neutrophils and lymphocytes are
affected by maltooligosaccharides.
Although our findings have suggested a previously
unrecognized biological regulatory pathway based
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upon maltooligosaccharides, there may be practical
applications of these findings. For example, biomate-
rials are often compromised by immunological
activation at their surfaces.27 By using maltooligo-
saccharides as a coating component, in analogy with
trophoblasts, it may be possible to improve the
biocompatibility of implants. This proposal is not
unreasonable because carbohydrates, such as hyal-
uronic acid, have already proven to be useful in
mitigating host responses to implant materials.
Indeed, maltooligosaccharide modification may be a
generally useful tool in reducing immuno-
logic ⁄ inflammatory responses to implants, polymeric
injectables, and other substances.
In summary, we have demonstrated that maltooli-
gosaccharides are present at the surface of JEG-3
trophoblasts. Further studies on the biochemical and
physiological properties of maltooligosaccharides are
underway. From a biological perspective, maltooligo-
saccharides would be expected to be an excellent
immunological evasion tactic. As a component of
glycogen, maltooligosaccharides are an ancient self-
molecule. More importantly, as glycogen is a compo-
nent of normal human serum (5 mg ⁄ 100 mL28),
mothers producing an anti-maltooligosaccharide
antibody would succumb to serum sickness. More-
over, we have also shown that these molecules are
capable of influencing the behavior of leukocytes.
We suggest that maltooligosaccharides contribute to
the carbohydrate surface coat of JEG-3 cells. To
examine maltooligosaccharide expression in human
placental tissue, we are developing novel fluorescent
tools. We speculate that maltooligosaccharides may
contribute to the mitigation of adaptive and innate
immunologic responses at the maternal–fetal inter-
face.
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